𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naïve patient

✍ Scribed by Jin-Jun Guo; Qing-Ling Li; Xiao-Feng Shi; Da-Zhi Zhang; Ai-Zhong Zeng; Tao Feng; Ai-Long Huang

Book ID
113457869
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
252 KB
Volume
81
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Entecavir resistance is rare in nucleosi
Entecavir resistance is rare in nucleoside naïve patients with hepatitis B
✍ Richard J. Colonno; Ronald Rose; Carl J. Baldick; Steven Levine; Kevin Pokornows 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

a HBV DNA Ͻ7 ϫ 10 5 copies/mL by bDNA assay ϩ loss of HBeAg (Study AI463022) or normalization of ALT (Study AI463027). b HBV DNA Ͻ7 ϫ 10 5 copies/mL by bDNA assay. c HBV DNA Ն7 ϫ 10 5 copies/mL by bDNA assay.

Long-term monitoring shows hepatitis B v
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy
✍ Daniel J. Tenney; Ronald E. Rose; Carl J. Baldick; Kevin A. Pokornowski; Betsy J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 742 KB

Patients with chronic hepatitis B virus (HBV) infection who develop antiviral resistance lose benefits of therapy and may be predisposed to further resistance. Entecavir (ETV) resistance (ETVr) results from HBV reverse transcriptase substitutions at positions T184, S202, or M250, which emerge in the